DOXYCLYCLINE HYCLATE

DOXYCLYCLINE HYCLATE was reported 17442 times

DOXYCLYCLINE HYCLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 110 0.4803
1 SWOLLEN JOINT COUNT 95 0.3800
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 227 0.3398
3 LUPUS VULGARIS 392 0.3111
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 519 0.2591
5 CONGENITAL HIATUS HERNIA 55 0.2412
6 RETINITIS 314 0.1816
7 C-REACTIVE PROTEIN 166 0.1791
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 369 0.1779
9 SWOLLEN JOINT COUNT INCREASED 492 0.1541
10 DISLOCATION OF VERTEBRA 339 0.1485
11 SERONEGATIVE ARTHRITIS 163 0.1422
12 X-RAY ABNORMAL 243 0.1358
13 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 13 0.1238
14 RHEUMATIC FEVER 548 0.1228
15 OVERLAP SYNDROME 85 0.1214
16 FACET JOINT SYNDROME 384 0.1178
17 RHEUMATOID FACTOR POSITIVE 629 0.1088
18 BONE EROSION 360 0.1017
19 GASTROINTESTINAL MUCOSAL NECROSIS 14 0.0966
20 PORPHYRIA ACUTE 138 0.0962
21 MALIGNANT MELANOMA STAGE 0 19 0.0909
22 DUODENAL ULCER PERFORATION 650 0.0873
23 DRUG TOLERANCE DECREASED 212 0.0754
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 42 0.0749
25 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 39 0.0746
26 C-REACTIVE PROTEIN ABNORMAL 478 0.0744
27 INTESTINAL SEPSIS 19 0.0725
28 MUSCLE INJURY 570 0.0687
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 489 0.0682
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 440 0.0677
31 HELICOBACTER INFECTION 689 0.0670
32 HYPOCHOLESTEROLAEMIA 23 0.0652
33 PERIPHERAL VENOUS DISEASE 262 0.0641
34 GRANULOMA SKIN 52 0.0633
35 FOLLICULITIS 649 0.0618
36 BREAST CANCER STAGE III 358 0.0552
37 AUTOIMMUNE DISORDER 527 0.0540
38 HAND DEFORMITY 678 0.0516
39 HYPERCHOLESTEROLAEMIA 499 0.0516
40 PEMPHIGUS 573 0.0458
41 GRIP STRENGTH DECREASED 401 0.0455
42 WOUND INFECTION 477 0.0435
43 JOINT RANGE OF MOTION DECREASED 555 0.0413
44 EXOSTOSIS 367 0.0401
45 LIP DRY 352 0.0387
46 SYNOVITIS 678 0.0376
47 BLOOD PARATHYROID HORMONE DECREASED 55 0.0371
48 LUPUS-LIKE SYNDROME 332 0.0366
49 JARISCH-HERXHEIMER REACTION 26 0.0365
50 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 38 0.0358
51 BRONCHIAL HYPERREACTIVITY 43 0.0357
52 PERICARDITIS 591 0.0351
53 WALKING AID USER 231 0.0350
54 RED BLOOD CELL SEDIMENTATION RATE INCREASED 381 0.0344
55 SCIATICA 534 0.0335
56 PERIORBITAL PAIN 27 0.0319
57 BREATH SOUNDS ABNORMAL 154 0.0312
58 BURSITIS 375 0.0309
59 GLOSSODYNIA 677 0.0302
60 IRRITABLE BOWEL SYNDROME 640 0.0298
61 JOINT DISLOCATION 313 0.0296
62 FIBROMYALGIA 691 0.0284
63 MATERNAL EXPOSURE TIMING UNSPECIFIED 106 0.0282
64 SKIN NEOPLASM EXCISION 22 0.0281
65 LOWER LIMB FRACTURE 540 0.0281
66 FOOT DEFORMITY 310 0.0279
67 MALIGNANT MELANOMA IN SITU 34 0.0274
68 ALLERGY TO PLANTS 12 0.0263
69 SPONDYLITIS 93 0.0255
70 PULMONARY FUNCTION TEST ABNORMAL 39 0.0250
71 PULMONARY FIBROSIS 471 0.0245
72 LIVE BIRTH 205 0.0245
73 WOUND 672 0.0240
74 RHEUMATOID NODULE 63 0.0229
75 PANNICULITIS 55 0.0227
76 PRESCRIBED UNDERDOSE 453 0.0227
77 HYPERPARATHYROIDISM SECONDARY 56 0.0223
78 PRESCRIBED OVERDOSE 431 0.0223
79 IMPAIRED HEALING 731 0.0222
80 INFUSION SITE DISCHARGE 39 0.0222
81 LIVER INJURY 538 0.0219
82 TYPE 2 DIABETES MELLITUS 679 0.0201
83 HEPATIC CIRRHOSIS 376 0.0200
84 NEPHROGENIC ANAEMIA 91 0.0196
85 HIP ARTHROPLASTY 289 0.0189
86 SPINAL FUSION SURGERY 76 0.0187
87 SYSTEMIC LUPUS ERYTHEMATOSUS 664 0.0187
88 OBESITY 294 0.0184
89 CHOLANGITIS SCLEROSING 37 0.0180
90 LYME DISEASE 59 0.0177
91 EYELID PAIN 35 0.0172
92 REBOUND ACID HYPERSECRETION 51 0.0168
93 INFUSION SITE REACTION 50 0.0167
94 EAR INFECTION 434 0.0163
95 NEOPLASM SKIN 25 0.0161
96 CONTRAINDICATED PRODUCT ADMINISTERED 469 0.0155
97 PSORIATIC ARTHROPATHY 615 0.0151
98 ONYCHOMADESIS 62 0.0148
99 GAIT INABILITY 475 0.0142
100 ROAD TRAFFIC ACCIDENT 587 0.0140
101 KNEE ARTHROPLASTY 285 0.0135
102 OSTEOARTHRITIS 571 0.0135
103 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 228 0.0134
104 JOINT STIFFNESS 351 0.0134
105 ISCHAEMIC CARDIOMYOPATHY 41 0.0134
106 WHEEZING 781 0.0132
107 BENIGN PROSTATIC HYPERPLASIA 68 0.0132
108 BLEPHAROSPASM 82 0.0130
109 ESSENTIAL HYPERTENSION 23 0.0126
110 BONE DEMINERALISATION 13 0.0123
111 GASTROINTESTINAL INJURY 33 0.0123
112 ROSACEA 57 0.0122
113 JOINT DESTRUCTION 19 0.0122
114 BLOOD CHOLESTEROL INCREASED 567 0.0122
115 INFUSION RELATED REACTION 793 0.0120
116 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16 0.0118
117 ASPERGILLUS INFECTION 77 0.0117
118 ARTHROPATHY 651 0.0117
119 ULCER HAEMORRHAGE 79 0.0117
120 DRUG TOLERANCE 59 0.0117
121 C-REACTIVE PROTEIN INCREASED 421 0.0116
122 EYE INJURY 35 0.0115
123 INFUSION SITE PRURITUS 36 0.0114
124 HEPATIC ENZYME INCREASED 772 0.0113
125 BLISTER 635 0.0113
126 WEIGHT FLUCTUATION 117 0.0112
127 PUSTULAR PSORIASIS 38 0.0111
128 GROIN ABSCESS 13 0.0110
129 SUBRETINAL FLUID 12 0.0110
130 ACQUIRED HAEMOPHILIA 11 0.0110
131 BRONCHIECTASIS 74 0.0110
132 DELIRIUM 377 0.0109
133 SKIN NECROSIS 56 0.0108
134 LOWER RESPIRATORY TRACT INFECTION 486 0.0107
135 OEDEMA 567 0.0104
136 NIGHT SWEATS 335 0.0104
137 INFUSION SITE BRUISING 22 0.0102
138 BREAST CANCER STAGE II 84 0.0101
139 STOMATITIS 608 0.0100
140 DISCOMFORT 611 0.0100
141 OSTEOPOROSIS 411 0.0100
142 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 168 0.0098
143 IDIOPATHIC INTRACRANIAL HYPERTENSION 22 0.0098
144 MOBILITY DECREASED 701 0.0097
145 INFUSION SITE HAEMORRHAGE 32 0.0097
146 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 460 0.0096
147 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 22 0.0095
148 INJURY 668 0.0095
149 SINUSITIS 970 0.0095
150 END STAGE RENAL DISEASE 171 0.0094
151 DISABILITY 185 0.0093
152 LIVER DISORDER 400 0.0090
153 INFLAMMATION 465 0.0090
154 PREGNANCY 179 0.0089
155 UPPER RESPIRATORY TRACT INFECTION 412 0.0089
156 LIVER FUNCTION TEST INCREASED 191 0.0089
157 RASH VESICULAR 43 0.0089
158 OBSTRUCTIVE AIRWAYS DISORDER 98 0.0088
159 PARANASAL SINUS DISCOMFORT 33 0.0087
160 PRE-EXISTING CONDITION IMPROVED 54 0.0086
161 NAIL DISORDER 75 0.0086
162 THERAPEUTIC PRODUCT EFFECT DECREASED 380 0.0085
163 SEASONAL ALLERGY 120 0.0085
164 MULTIPLE ALLERGIES 65 0.0083
165 PRODUCT ADMINISTRATION INTERRUPTED 64 0.0081
166 LUNG DISORDER 389 0.0079
167 MUSCULOSKELETAL STIFFNESS 692 0.0079
168 RHEUMATOID ARTHRITIS 879 0.0077
169 NORMAL NEWBORN 42 0.0077
170 ATROPHY 15 0.0077
171 HIDRADENITIS 70 0.0077
172 SLEEP DISORDER 541 0.0077
173 DRUG-INDUCED LIVER INJURY 240 0.0076
174 SUSPECTED OFF LABEL USE 34 0.0075
175 EAR PAIN 146 0.0075
176 SWELLING 702 0.0075
177 DRUG INTOLERANCE 723 0.0075
178 CHRONIC KIDNEY DISEASE 559 0.0073
179 CATHETER SITE PAIN 19 0.0073
180 INFUSION SITE SWELLING 46 0.0073
181 OESOPHAGEAL ULCER 28 0.0073
182 VASCULAR DEVICE INFECTION 33 0.0073
183 ASTHMA 822 0.0073
184 FOREIGN BODY SENSATION IN EYES 46 0.0072
185 ILL-DEFINED DISORDER 430 0.0071
186 ONYCHOMYCOSIS 31 0.0071
187 METAMORPHOPSIA 13 0.0070
188 CATHETER SITE ERYTHEMA 15 0.0070
189 FULL BLOOD COUNT ABNORMAL 74 0.0070
190 MUSCULOSKELETAL PAIN 366 0.0070
191 INFECTION 993 0.0069
192 DEVICE INFUSION ISSUE 17 0.0068
193 PULMONARY PAIN 20 0.0068
194 ARTHRITIS 538 0.0068
195 TACHYARRHYTHMIA 17 0.0068
196 JOINT SWELLING 821 0.0068
197 MATERNAL EXPOSURE DURING PREGNANCY 599 0.0067
198 CONGENITAL ANOMALY 52 0.0067
199 CONTUSION 646 0.0067
200 CYTOPENIA 82 0.0067
201 AMNESIA 426 0.0065
202 EYELID IRRITATION 16 0.0064
203 GASTROINTESTINAL DISORDER 571 0.0064
204 RESPIRATORY DISORDER 190 0.0063
205 BRONCHITIS 461 0.0062
206 DERMATITIS CONTACT 71 0.0062
207 GENERAL PHYSICAL HEALTH DETERIORATION 715 0.0062
208 FREQUENT BOWEL MOVEMENTS 165 0.0061
209 EYE PAIN 343 0.0061
210 HYPERVOLAEMIA 30 0.0061
211 THERAPY NON-RESPONDER 272 0.0060
212 DRY MOUTH 488 0.0060
213 HORDEOLUM 26 0.0060
214 HYPOAESTHESIA 890 0.0059
215 INFUSION SITE ERYTHEMA 50 0.0059
216 CHRONIC SINUSITIS 22 0.0059
217 APPARENT DEATH 21 0.0058
218 ECONOMIC PROBLEM 88 0.0058
219 CYSTIC FIBROSIS 32 0.0058
220 TREATMENT FAILURE 470 0.0057
221 MICTURITION URGENCY 64 0.0056
222 CATHETER SITE HAEMORRHAGE 14 0.0056
223 INFUSION SITE PAIN 72 0.0056
224 PERIPHERAL SWELLING 857 0.0056
225 PARANASAL SINUS HYPERSECRETION 21 0.0055
226 SKIN ABRASION 26 0.0055
227 MYOSITIS 49 0.0055
228 DYSPEPSIA 537 0.0055
229 ABDOMINAL DISCOMFORT 906 0.0054
230 CHOLESTATIC LIVER INJURY 12 0.0054
231 PHOTOPHOBIA 101 0.0054
232 OCULAR DISCOMFORT 60 0.0053
233 ULCER 85 0.0053
234 BASAL CELL CARCINOMA 83 0.0053
235 HYPERCALCAEMIA 65 0.0053
236 INTENTIONAL PRODUCT USE ISSUE 456 0.0052
237 PLEURITIC PAIN 14 0.0051
238 URTICARIA 849 0.0051
239 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 355 0.0050
240 HYPERSENSITIVITY 925 0.0050
241 PRODUCT LABEL CONFUSION 29 0.0050
242 LABORATORY TEST ABNORMAL 146 0.0049
243 HYPERTRANSAMINASAEMIA 34 0.0049
244 SKIN ULCER 126 0.0049
245 COLITIS ULCERATIVE 217 0.0048
246 ANHEDONIA 126 0.0048
247 BACK INJURY 52 0.0048
248 INSURANCE ISSUE 73 0.0048
249 TOOTH DISCOLOURATION 14 0.0048
250 INFUSION SITE INFECTION 11 0.0047
251 SKIN INFECTION 53 0.0047
252 PNEUMONIA VIRAL 15 0.0047
253 NASOPHARYNGITIS 862 0.0047
254 OESOPHAGITIS 51 0.0047
255 HYPERTENSION 979 0.0046
256 WHITE BLOOD CELL COUNT INCREASED 177 0.0046
257 TENDERNESS 48 0.0046
258 LYMPHOCYTE COUNT INCREASED 15 0.0046
259 PAINFUL RESPIRATION 11 0.0046
260 TASTE DISORDER 92 0.0045
261 GASTRITIS EROSIVE 21 0.0045
262 ANIMAL BITE 12 0.0045
263 TUBULOINTERSTITIAL NEPHRITIS 84 0.0045
264 OEDEMA PERIPHERAL 546 0.0045
265 MUSCULAR WEAKNESS 509 0.0045
266 INCORRECT DRUG ADMINISTRATION RATE 19 0.0045
267 ARTHROPOD BITE 33 0.0044
268 BREAST CANCER STAGE I 41 0.0044
269 MIGRAINE 416 0.0044
270 DRUG ERUPTION 77 0.0043
271 INFUSION SITE EXTRAVASATION 27 0.0043
272 CONFUSIONAL STATE 699 0.0043
273 ARTHRITIS INFECTIVE 20 0.0043
274 OESOPHAGEAL PAIN 17 0.0043
275 SUNBURN 32 0.0043
276 RESPIRATORY TRACT INFECTION 111 0.0043
277 OBSTRUCTION 17 0.0043
278 DEPRESSIVE SYMPTOM 15 0.0043
279 ALOPECIA 826 0.0042
280 ANXIETY DISORDER 14 0.0042
281 HEPATITIS 106 0.0041
282 RECTAL HAEMORRHAGE 177 0.0041
283 VISUAL IMPAIRMENT 508 0.0041
284 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
285 MEMORY IMPAIRMENT 560 0.0041
286 PHOTOSENSITIVITY REACTION 67 0.0041
287 GASTRIC PERFORATION 11 0.0040
288 CREPITATIONS 12 0.0040
289 ATYPICAL PNEUMONIA 12 0.0040
290 PRODUCTIVE COUGH 191 0.0040
291 EPILEPSY 122 0.0040
292 SINUS DISORDER 79 0.0040
293 ABSCESS LIMB 17 0.0040
294 POLYARTHRITIS 21 0.0040
295 SLEEP APNOEA SYNDROME 76 0.0040
296 COELIAC DISEASE 39 0.0040
297 NECROTISING FASCIITIS 14 0.0040
298 HAEMOGLOBIN INCREASED 18 0.0039
299 DERMATITIS ACNEIFORM 24 0.0039
300 CHEST PAIN 723 0.0039
301 ORAL INFECTION 15 0.0038
302 SWELLING OF EYELID 24 0.0038
303 PHARYNGITIS STREPTOCOCCAL 41 0.0038
304 OSTEOPENIA 57 0.0038
305 BACK DISORDER 61 0.0037
306 NEPHROPATHY 35 0.0037
307 BLEPHARITIS 15 0.0037
308 EYE INFECTION 42 0.0037
309 GASTROOESOPHAGEAL REFLUX DISEASE 299 0.0037
310 SNORING 14 0.0037
311 JOINT INJURY 79 0.0037
312 DYSPNOEA EXERTIONAL 139 0.0037
313 DECREASED APPETITE 851 0.0037
314 DEAFNESS NEUROSENSORY 12 0.0036
315 WEIGHT INCREASED 815 0.0036
316 RASH PRURITIC 196 0.0036
317 CONDITION AGGRAVATED 1094 0.0036
318 INTRACRANIAL PRESSURE INCREASED 20 0.0036
319 WOUND SECRETION 14 0.0036
320 FIBROSIS 11 0.0036
321 PNEUMONIA 1157 0.0036
322 PERIORBITAL SWELLING 20 0.0035
323 TOOTH ABSCESS 36 0.0035
324 PANCREATITIS 186 0.0035
325 EXPOSURE DURING PREGNANCY 217 0.0035
326 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 19 0.0035
327 IMPAIRED QUALITY OF LIFE 50 0.0035
328 LOCALISED INFECTION 84 0.0035
329 GENERAL SYMPTOM 26 0.0035
330 MUSCLE SPASTICITY 42 0.0034
331 ANTINUCLEAR ANTIBODY POSITIVE 11 0.0034
332 FEELING HOT 207 0.0034
333 ANXIETY 959 0.0034
334 FACIAL PAIN 30 0.0034
335 RASH 1463 0.0034
336 PRODUCT DISTRIBUTION ISSUE 31 0.0033
337 TOOTH INFECTION 44 0.0033
338 VITAMIN D DEFICIENCY 32 0.0033
339 FURUNCLE 26 0.0033
340 PLANTAR FASCIITIS 11 0.0033
341 SINUS CONGESTION 44 0.0033
342 VITREOUS FLOATERS 32 0.0033
343 CARDIOMYOPATHY 48 0.0032
344 GAIT DISTURBANCE 617 0.0032
345 RENAL FAILURE 425 0.0032
346 MELANOCYTIC NAEVUS 14 0.0032
347 ORAL CANDIDIASIS 42 0.0032
348 AUTOIMMUNE THYROIDITIS 12 0.0032
349 ADVERSE EVENT 291 0.0032
350 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
351 SPINAL STENOSIS 13 0.0031
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 164 0.0031
353 TERMINAL STATE 21 0.0031
354 HANGOVER 11 0.0031
355 DEPRESSION 711 0.0031
356 PRODUCT USE ISSUE 579 0.0031
357 CELLULITIS 153 0.0030
358 PRURITUS 1165 0.0030
359 PULMONARY THROMBOSIS 33 0.0030
360 ADVERSE DRUG REACTION 271 0.0030
361 INSOMNIA 801 0.0030
362 DERMATITIS 63 0.0030
363 ABDOMINAL PAIN UPPER 618 0.0030
364 RENAL TUBULAR NECROSIS 29 0.0030
365 POST PROCEDURAL INFECTION 24 0.0029
366 TRIGGER FINGER 12 0.0029
367 EAR DISCOMFORT 30 0.0029
368 CATHETER SITE INFECTION 11 0.0029
369 TEMPERATURE INTOLERANCE 30 0.0029
370 CANDIDA INFECTION 49 0.0029
371 JOINT EFFUSION 20 0.0029
372 FINGER DEFORMITY 14 0.0029
373 MAJOR DEPRESSION 21 0.0029
374 SINUS HEADACHE 17 0.0029
375 EYE SWELLING 106 0.0028
376 VOMITING 1337 0.0028
377 GASTROENTERITIS VIRAL 51 0.0028
378 WEIGHT DECREASED 787 0.0028
379 PURULENT DISCHARGE 12 0.0028
380 RENAL INJURY 83 0.0028
381 PEMPHIGOID 21 0.0028
382 LACRIMATION INCREASED 84 0.0028
383 MEDICATION ERROR 154 0.0028
384 VAGINAL INFECTION 13 0.0028
385 ONYCHOCLASIS 19 0.0028
386 SKIN WARM 16 0.0027
387 CONJUNCTIVITIS 51 0.0027
388 LYMPHOEDEMA 19 0.0027
389 DRY EYE 137 0.0027
390 DIVERTICULUM INTESTINAL 12 0.0027
391 SPUTUM DISCOLOURED 26 0.0027
392 NECK PAIN 153 0.0027
393 RHINITIS 22 0.0027
394 EYE IRRITATION 157 0.0027
395 MUSCLE SPASMS 499 0.0027
396 APPETITE DISORDER 18 0.0027
397 PRODUCT USE IN UNAPPROVED INDICATION 671 0.0027
398 STREPTOCOCCAL INFECTION 15 0.0027
399 ODYNOPHAGIA 16 0.0027
400 SQUAMOUS CELL CARCINOMA OF SKIN 16 0.0026
401 LIGAMENT SPRAIN 26 0.0026
402 FUNGAL INFECTION 87 0.0026
403 QUALITY OF LIFE DECREASED 35 0.0026
404 TRANSIENT ISCHAEMIC ATTACK 88 0.0026
405 STAPHYLOCOCCAL INFECTION 86 0.0026
406 PAIN IN EXTREMITY 768 0.0026
407 NODULE 34 0.0026
408 AUTOIMMUNE HEPATITIS 18 0.0026
409 RESPIRATORY TRACT CONGESTION 41 0.0026
410 ILLNESS 265 0.0026
411 EOSINOPHILIA 45 0.0026
412 BRAIN FOG 40 0.0025
413 PARAESTHESIA 400 0.0025
414 COVID-19 PNEUMONIA 30 0.0025
415 PYREXIA 879 0.0025
416 THERAPEUTIC RESPONSE DECREASED 154 0.0025
417 TACHYCARDIA 225 0.0025
418 GROIN PAIN 22 0.0025
419 LIMB INJURY 68 0.0025
420 EYE DISCHARGE 26 0.0025
421 INCREASED TENDENCY TO BRUISE 23 0.0025
422 ARTHRALGIA 1039 0.0025
423 NERVE COMPRESSION 23 0.0025
424 ACUTE KIDNEY INJURY 381 0.0025
425 SKIN LACERATION 27 0.0025
426 FOOD ALLERGY 19 0.0025
427 DRY THROAT 25 0.0025
428 GASTROINTESTINAL INFECTION 22 0.0025
429 KIDNEY INFECTION 48 0.0024
430 ABSCESS 39 0.0024
431 BLOOD IRON DECREASED 29 0.0024
432 PAPILLOEDEMA 11 0.0024
433 BLOOD MAGNESIUM DECREASED 21 0.0024
434 OSTEOMYELITIS 44 0.0024
435 FOOD POISONING 13 0.0024
436 FOOT OPERATION 12 0.0024
437 PAIN 1489 0.0024
438 POOR VENOUS ACCESS 25 0.0024
439 IMMUNODEFICIENCY 36 0.0024
440 EYE INFLAMMATION 23 0.0024
441 GINGIVITIS 13 0.0024
442 OCULAR HYPERAEMIA 114 0.0024
443 BODY TEMPERATURE INCREASED 49 0.0024
444 SPINAL OSTEOARTHRITIS 21 0.0024
445 DIVERTICULITIS 66 0.0024
446 DYSPNOEA 1348 0.0024
447 NEPHROLITHIASIS 109 0.0024
448 PHOTOPSIA 15 0.0024
449 SKIN DISORDER 79 0.0024
450 FATIGUE 1818 0.0023
451 DEAFNESS 61 0.0023
452 PERIPHERAL VASCULAR DISORDER 12 0.0023
453 PSORIASIS 303 0.0023
454 MUSCLE STRAIN 20 0.0023
455 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0023
456 PRODUCT DOSE OMISSION IN ERROR 65 0.0023
457 SOMNAMBULISM 15 0.0023
458 RIB FRACTURE 47 0.0023
459 ASPIRATION 25 0.0023
460 CORONARY ARTERY DISEASE 69 0.0023
461 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
462 PHARYNGITIS 28 0.0023
463 CYST 28 0.0023
464 SKIN FISSURES 44 0.0022
465 FLUID RETENTION 114 0.0022
466 HEADACHE 1403 0.0022
467 OVERWEIGHT 12 0.0022
468 DIZZINESS 1114 0.0022
469 ARTERIOSCLEROSIS 21 0.0022
470 ANAL ABSCESS 12 0.0022
471 SCAR 38 0.0022
472 INFLAMMATORY MARKER INCREASED 11 0.0022
473 HIP SURGERY 12 0.0022
474 OROPHARYNGEAL PAIN 205 0.0022
475 UNDERDOSE 161 0.0022
476 CONCUSSION 17 0.0022
477 SURGERY 128 0.0022
478 ASTHENOPIA 12 0.0022
479 RHINORRHOEA 141 0.0022
480 MALAISE 952 0.0022
481 PSYCHIATRIC SYMPTOM 16 0.0022
482 CARDIAC FLUTTER 14 0.0022
483 NAUSEA 1709 0.0022
484 SKIN HAEMORRHAGE 32 0.0022
485 MUSCULOSKELETAL CHEST PAIN 33 0.0021
486 PAPULE 15 0.0021
487 HOSPICE CARE 21 0.0021
488 DIARRHOEA 1368 0.0021
489 HAND FRACTURE 15 0.0021
490 THROMBOCYTOPENIA 236 0.0021
491 OROPHARYNGEAL DISCOMFORT 19 0.0021
492 PSEUDOMONAS INFECTION 18 0.0021
493 HYPERLIPIDAEMIA 25 0.0021
494 POST-TRAUMATIC STRESS DISORDER 14 0.0021
495 WRIST FRACTURE 25 0.0021
496 ATRIAL FIBRILLATION 203 0.0021
497 PULMONARY MASS 31 0.0021
498 HYPERAESTHESIA 17 0.0021
499 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
500 ERYTHEMA OF EYELID 11 0.0020
501 NASAL CONGESTION 119 0.0020
502 ABDOMINAL PAIN 471 0.0020
503 NASAL DISCOMFORT 16 0.0020
504 SPINAL DISORDER 19 0.0020
505 FOOT FRACTURE 38 0.0020
506 FULL BLOOD COUNT DECREASED 40 0.0020
507 ASTHENIA 746 0.0020
508 RESTLESS LEGS SYNDROME 36 0.0020
509 ADRENAL INSUFFICIENCY 24 0.0020
510 FOETAL GROWTH RESTRICTION 12 0.0020
511 THERMAL BURN 14 0.0020
512 ATELECTASIS 19 0.0020
513 CARDIAC MURMUR 17 0.0020
514 SPINAL FRACTURE 39 0.0019
515 CHOLECYSTITIS CHRONIC 13 0.0019
516 PRODUCT DOSE OMISSION ISSUE 571 0.0019
517 URINARY TRACT INFECTION 331 0.0019
518 COUGH 544 0.0019
519 BLOOD POTASSIUM DECREASED 58 0.0019
520 POSTOPERATIVE WOUND INFECTION 13 0.0019
521 ORAL PAIN 43 0.0019
522 BONE DENSITY DECREASED 60 0.0019
523 NASAL DRYNESS 12 0.0019
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 105 0.0019
525 IMPAIRED GASTRIC EMPTYING 26 0.0019
526 MOUTH SWELLING 11 0.0019
527 TOOTH FRACTURE 21 0.0019
528 DENTAL CARIES 21 0.0019
529 DERMATITIS ATOPIC 100 0.0019
530 PERIPHERAL COLDNESS 26 0.0019
531 UTERINE PERFORATION 16 0.0019
532 TOOTHACHE 34 0.0019
533 TINNITUS 86 0.0019
534 SPINAL OPERATION 23 0.0019
535 COVID-19 327 0.0019
536 MASS 26 0.0019
537 SKIN REACTION 26 0.0018
538 FEELING JITTERY 35 0.0018
539 HEPATIC ENCEPHALOPATHY 17 0.0018
540 IMMUNE SYSTEM DISORDER 24 0.0018
541 FLANK PAIN 17 0.0018
542 LIMB DISCOMFORT 56 0.0018
543 HEAD DISCOMFORT 32 0.0018
544 SQUAMOUS CELL CARCINOMA 17 0.0018
545 SCRATCH 19 0.0018
546 PANIC REACTION 13 0.0018
547 MUSCULOSKELETAL DISCOMFORT 31 0.0018
548 COMPLICATION ASSOCIATED WITH DEVICE 26 0.0018
549 MENISCUS INJURY 11 0.0018
550 GASTRIC ULCER 34 0.0018
551 SKIN LESION 49 0.0018
552 EMPHYSEMA 18 0.0018
553 POOR QUALITY SLEEP 38 0.0018
554 BLOOD PRESSURE ABNORMAL 35 0.0018
555 VITAMIN D DECREASED 15 0.0018
556 DIZZINESS POSTURAL 17 0.0018
557 BLOOD PRESSURE FLUCTUATION 42 0.0017
558 ANKLE FRACTURE 27 0.0017
559 VIRAL INFECTION 58 0.0017
560 PHARYNGEAL SWELLING 17 0.0017
561 NEUROPATHY PERIPHERAL 165 0.0017
562 SKIN SWELLING 15 0.0017
563 CYSTITIS 55 0.0017
564 APHONIA 24 0.0017
565 DECUBITUS ULCER 14 0.0017
566 ACUTE RESPIRATORY FAILURE 33 0.0017
567 INFLUENZA 191 0.0017
568 CHEST DISCOMFORT 175 0.0017
569 THROAT IRRITATION 76 0.0017
570 EPISTAXIS 126 0.0017
571 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
572 EMOTIONAL DISTRESS 202 0.0017
573 DECREASED ACTIVITY 18 0.0017
574 NEUTROPHIL COUNT INCREASED 17 0.0017
575 INITIAL INSOMNIA 17 0.0017
576 NOCTURIA 20 0.0016
577 PATHOGEN RESISTANCE 15 0.0016
578 BACK PAIN 382 0.0016
579 RED BLOOD CELL COUNT DECREASED 47 0.0016
580 CARPAL TUNNEL SYNDROME 23 0.0016
581 ORAL HERPES 32 0.0016
582 INFLAMMATORY BOWEL DISEASE 16 0.0016
583 DRUG RESISTANCE 42 0.0016
584 OFF LABEL USE 1431 0.0016
585 PNEUMONIA BACTERIAL 15 0.0016
586 PRODUCT ADMINISTRATION ERROR 33 0.0016
587 PAIN IN JAW 46 0.0016
588 OXYGEN SATURATION DECREASED 91 0.0016
589 HERPES ZOSTER 93 0.0016
590 GOUT 29 0.0016
591 FEELING DRUNK 12 0.0016
592 BONE DISORDER 29 0.0016
593 BODY HEIGHT DECREASED 17 0.0016
594 SKIN EXFOLIATION 134 0.0016
595 HEREDITARY ANGIOEDEMA 17 0.0016
596 HICCUPS 13 0.0016
597 SKIN CANCER 34 0.0016
598 INTENTIONAL DOSE OMISSION 45 0.0016
599 SNEEZING 35 0.0016
600 ROTATOR CUFF SYNDROME 20 0.0016
601 BACTERIAL INFECTION 29 0.0016
602 LOW DENSITY LIPOPROTEIN INCREASED 12 0.0015
603 EYE PRURITUS 52 0.0015
604 HIATUS HERNIA 20 0.0015
605 RASH MACULAR 54 0.0015
606 PELVIC FRACTURE 12 0.0015
607 HAEMORRHOIDS 30 0.0015
608 HYPERSOMNIA 44 0.0015
609 NERVE INJURY 17 0.0015
610 SECRETION DISCHARGE 19 0.0015
611 PULMONARY CONGESTION 20 0.0015
612 BLOOD COUNT ABNORMAL 23 0.0015
613 HEAD INJURY 48 0.0015
614 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
615 ORAL DISCOMFORT 21 0.0015
616 GINGIVAL PAIN 12 0.0015
617 RETCHING 32 0.0015
618 TREATMENT NONCOMPLIANCE 82 0.0015
619 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 268 0.0015
620 BLOOD SODIUM DECREASED 28 0.0015
621 TOOTH DISORDER 33 0.0015
622 BIPOLAR DISORDER 16 0.0015
623 MUSCULOSKELETAL DISORDER 28 0.0015
624 PANCREATITIS ACUTE 33 0.0015
625 VISION BLURRED 201 0.0015
626 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
627 CARDIOMEGALY 18 0.0015
628 PULMONARY ARTERIAL HYPERTENSION 21 0.0014
629 AGEUSIA 36 0.0014
630 HOSPITALISATION 220 0.0014
631 BLOOD TEST ABNORMAL 20 0.0014
632 KNEE OPERATION 14 0.0014
633 BLOOD URINE PRESENT 27 0.0014
634 SKIN DISCOLOURATION 65 0.0014
635 BLADDER DISORDER 14 0.0014
636 HAEMORRHAGE 147 0.0014
637 GASTRITIS 37 0.0014
638 SCAB 16 0.0014
639 TOOTH LOSS 29 0.0014
640 ASPARTATE AMINOTRANSFERASE INCREASED 74 0.0014
641 HEPATOTOXICITY 31 0.0014
642 FEBRILE NEUTROPENIA 92 0.0014
643 DRY SKIN 185 0.0014
644 THERAPEUTIC RESPONSE UNEXPECTED 62 0.0014
645 THROMBOSIS 111 0.0014
646 ECZEMA 72 0.0014
647 DEHYDRATION 183 0.0014
648 HEART RATE IRREGULAR 31 0.0014
649 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
650 HYPOMAGNESAEMIA 19 0.0014
651 SARS-COV-2 TEST POSITIVE 18 0.0014
652 STEVENS-JOHNSON SYNDROME 30 0.0013
653 EYE HAEMORRHAGE 18 0.0013
654 PULMONARY HYPERTENSION 28 0.0013
655 HEPATIC STEATOSIS 25 0.0013
656 MUSCLE ATROPHY 17 0.0013
657 MALNUTRITION 15 0.0013
658 DEEP VEIN THROMBOSIS 87 0.0013
659 CARDIAC DISORDER 125 0.0013
660 FISTULA 15 0.0013
661 PRODUCT USE COMPLAINT 21 0.0013
662 HYPOPHAGIA 34 0.0013
663 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
664 DYSPHAGIA 126 0.0013
665 CONSTIPATION 289 0.0013
666 RENAL PAIN 14 0.0013
667 PARAESTHESIA ORAL 19 0.0013
668 EXPOSURE VIA SKIN CONTACT 34 0.0013
669 FALL 433 0.0013
670 IRON DEFICIENCY ANAEMIA 12 0.0013
671 LEUKOPENIA 65 0.0013
672 THYROID DISORDER 20 0.0013
673 TOOTH EXTRACTION 16 0.0013
674 HEART RATE INCREASED 127 0.0013
675 MULTIPLE FRACTURES 21 0.0013
676 NEURALGIA 31 0.0013
677 BACTERAEMIA 15 0.0013
678 PROCEDURAL PAIN 35 0.0013
679 THROAT TIGHTNESS 34 0.0013
680 HAEMOPTYSIS 35 0.0013
681 PERICARDIAL EFFUSION 29 0.0013
682 ALANINE AMINOTRANSFERASE INCREASED 77 0.0013
683 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
684 ERYTHEMA 257 0.0012
685 POST PROCEDURAL COMPLICATION 24 0.0012
686 DYSPHONIA 73 0.0012
687 ABORTION SPONTANEOUS 50 0.0012
688 ABDOMINAL DISTENSION 130 0.0012
689 HIP FRACTURE 40 0.0012
690 SEPSIS 138 0.0012
691 DIABETES MELLITUS 94 0.0012
692 SWELLING FACE 80 0.0012
693 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
694 ABDOMINAL PAIN LOWER 31 0.0012
695 CATARACT 73 0.0012
696 INTERNAL HAEMORRHAGE 14 0.0012
697 HOT FLUSH 92 0.0012
698 SMALL INTESTINAL OBSTRUCTION 15 0.0012
699 BEDRIDDEN 16 0.0012
700 UNEVALUABLE EVENT 92 0.0012
701 LYMPHADENOPATHY 43 0.0012
702 HAIR COLOUR CHANGES 15 0.0012
703 UPPER LIMB FRACTURE 24 0.0012
704 THERAPY INTERRUPTED 86 0.0012
705 BALANCE DISORDER 104 0.0012
706 SALIVARY HYPERSECRETION 12 0.0012
707 INTENTIONAL PRODUCT MISUSE 105 0.0012
708 HAIR TEXTURE ABNORMAL 16 0.0012
709 DIPLOPIA 31 0.0012
710 RASH ERYTHEMATOUS 57 0.0012
711 DEPRESSED MOOD 63 0.0012
712 BRONCHOSPASM 17 0.0012
713 FEEDING DISORDER 24 0.0012
714 RENAL IMPAIRMENT 99 0.0012
715 BONE PAIN 69 0.0012
716 DEFORMITY 11 0.0012
717 POLLAKIURIA 49 0.0012
718 HYPERTHYROIDISM 17 0.0012
719 ACCIDENT 14 0.0012
720 ACUTE HEPATIC FAILURE 16 0.0012
721 CARDIAC FAILURE CONGESTIVE 94 0.0012
722 HYPOKALAEMIA 54 0.0012
723 BURNING SENSATION 82 0.0012
724 FEELING ABNORMAL 279 0.0012
725 LOSS OF CONSCIOUSNESS 149 0.0012
726 ANAEMIA 221 0.0012
727 PELVIC PAIN 21 0.0012
728 FEELING COLD 32 0.0011
729 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
730 BLOOD PRESSURE DECREASED 76 0.0011
731 RENAL DISORDER 53 0.0011
732 ADVERSE REACTION 15 0.0011
733 NEOPLASM 13 0.0011
734 BONE LOSS 17 0.0011
735 THINKING ABNORMAL 21 0.0011
736 MIDDLE INSOMNIA 21 0.0011
737 MALIGNANT MELANOMA 15 0.0011
738 BLOOD PRESSURE INCREASED 171 0.0011
739 PLEURAL EFFUSION 68 0.0011
740 BODY TEMPERATURE DECREASED 11 0.0011
741 DERMATITIS ALLERGIC 14 0.0011
742 HAEMATURIA 38 0.0011
743 WHITE BLOOD CELL COUNT DECREASED 120 0.0011
744 ANOSMIA 16 0.0011
745 TENDONITIS 17 0.0011
746 GASTROINTESTINAL PAIN 12 0.0011
747 DYSURIA 40 0.0011
748 LIP SWELLING 36 0.0011
749 HYPOXIA 38 0.0011
750 GASTRIC DISORDER 37 0.0011
751 COLD SWEAT 19 0.0011
752 PAIN OF SKIN 29 0.0011
753 HUNGER 15 0.0011
754 CHILLS 126 0.0011
755 DRUG INEFFECTIVE 1414 0.0011
756 PANIC ATTACK 39 0.0011
757 HALLUCINATION, AUDITORY 17 0.0011
758 BLOOD CALCIUM DECREASED 12 0.0011
759 GALLBLADDER DISORDER 19 0.0011
760 MITRAL VALVE INCOMPETENCE 12 0.0011
761 HAEMATOCRIT DECREASED 21 0.0011
762 PRODUCT DOSE OMISSION 69 0.0011
763 ACNE 80 0.0011
764 VERTIGO 64 0.0010
765 BLOOD POTASSIUM INCREASED 17 0.0010
766 URINARY INCONTINENCE 31 0.0010
767 INCONTINENCE 11 0.0010
768 FLATULENCE 59 0.0010
769 SUICIDAL IDEATION 95 0.0010
770 HYPOTHYROIDISM 33 0.0010
771 EATING DISORDER 22 0.0010
772 DYSSTASIA 30 0.0010
773 PULMONARY OEDEMA 46 0.0010
774 CHROMATURIA 23 0.0010
775 MYALGIA 173 0.0010
776 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
777 HALLUCINATION 76 0.0010
778 CHOLELITHIASIS 33 0.0010
779 TREMOR 167 0.0010
780 FRACTURE 19 0.0010
781 EYE DISORDER 33 0.0010
782 PULMONARY EMBOLISM 95 0.0010
783 NEEDLE ISSUE 29 0.0010
784 SWOLLEN TONGUE 31 0.0010
785 PALPITATIONS 116 0.0010
786 MUSCLE TIGHTNESS 16 0.0010
787 PARANOIA 17 0.0010
788 NEUTROPENIA 133 0.0010
789 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
790 DEVICE USE ISSUE 17 0.0010
791 IMPAIRED DRIVING ABILITY 11 0.0010
792 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
793 ANAPHYLACTIC REACTION 53 0.0010
794 HYPERHIDROSIS 123 0.0010
795 ASCITES 28 0.0010
796 HYPOGLYCAEMIA 46 0.0009
797 PLASMA CELL MYELOMA 37 0.0009
798 HALLUCINATION, VISUAL 20 0.0009
799 PNEUMOTHORAX 15 0.0009
800 RASH MACULO-PAPULAR 21 0.0009
801 NERVOUSNESS 49 0.0009
802 GLAUCOMA 18 0.0009
803 FEAR 25 0.0009
804 INCORRECT PRODUCT ADMINISTRATION DURATION 20 0.0009
805 BLINDNESS UNILATERAL 13 0.0009
806 ORTHOSTATIC HYPOTENSION 16 0.0009
807 SOMNOLENCE 185 0.0009
808 PHARYNGEAL OEDEMA 14 0.0009
809 MOOD SWINGS 29 0.0009
810 ABNORMAL DREAMS 25 0.0009
811 PRESYNCOPE 22 0.0009
812 ACCIDENTAL OVERDOSE 33 0.0009
813 EJECTION FRACTION DECREASED 14 0.0009
814 COAGULOPATHY 15 0.0009
815 LIVER FUNCTION TEST ABNORMAL 26 0.0009
816 HYPOTENSION 179 0.0009
817 INCREASED APPETITE 17 0.0009
818 IMPAIRED WORK ABILITY 19 0.0009
819 HAEMOGLOBIN DECREASED 91 0.0009
820 HEART RATE DECREASED 31 0.0009
821 HERNIA 17 0.0009
822 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
823 PLATELET COUNT DECREASED 92 0.0009
824 HYPOAESTHESIA ORAL 13 0.0009
825 LETHARGY 49 0.0009
826 INFLUENZA LIKE ILLNESS 70 0.0008
827 SEPTIC SHOCK 37 0.0008
828 PSYCHOTIC DISORDER 25 0.0008
829 THIRST 15 0.0008
830 SKIN BURNING SENSATION 60 0.0008
831 DYSKINESIA 34 0.0008
832 THERAPY PARTIAL RESPONDER 13 0.0008
833 DISORIENTATION 33 0.0008
834 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
835 GLYCOSYLATED HAEMOGLOBIN INCREASED 21 0.0008
836 SKIN IRRITATION 38 0.0008
837 SYNCOPE 83 0.0008
838 RESPIRATORY FAILURE 60 0.0008
839 CHOKING 16 0.0008
840 COGNITIVE DISORDER 38 0.0008
841 TRANSAMINASES INCREASED 18 0.0008
842 PNEUMONITIS 22 0.0008
843 FEMUR FRACTURE 25 0.0008
844 HAEMATOCHEZIA 44 0.0008
845 BLOOD CREATININE INCREASED 52 0.0008
846 SUICIDE ATTEMPT 48 0.0008
847 PRODUCT AVAILABILITY ISSUE 18 0.0008
848 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
849 INJECTION SITE REACTION 54 0.0008
850 FAECES DISCOLOURED 17 0.0008
851 MUSCLE TWITCHING 18 0.0008
852 NIGHTMARE 27 0.0008
853 BLOOD UREA INCREASED 13 0.0008
854 ERUCTATION 15 0.0008
855 DYSARTHRIA 29 0.0008
856 HYPOACUSIS 33 0.0008
857 INTERSTITIAL LUNG DISEASE 37 0.0008
858 OSTEONECROSIS 25 0.0008
859 DISTURBANCE IN ATTENTION 41 0.0008
860 MENTAL STATUS CHANGES 21 0.0008
861 FLUID OVERLOAD 11 0.0008
862 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
863 LYMPHOCYTE COUNT DECREASED 13 0.0007
864 RASH GENERALISED 19 0.0007
865 HAEMATOMA 19 0.0007
866 FLUSHING 74 0.0007
867 OSTEONECROSIS OF JAW 18 0.0007
868 RASH PAPULAR 16 0.0007
869 DEVICE DISLOCATION 31 0.0007
870 LUNG INFECTION 11 0.0007
871 IRRITABILITY 42 0.0007
872 INTESTINAL OBSTRUCTION 26 0.0007
873 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
874 INJECTION SITE BRUISING 53 0.0007
875 LEUKOCYTOSIS 12 0.0007
876 INJECTION SITE PRURITUS 44 0.0007
877 MOVEMENT DISORDER 21 0.0007
878 INJECTION SITE SWELLING 50 0.0007
879 SEIZURE 75 0.0006
880 DRUG INTERACTION 103 0.0006
881 THERAPY CESSATION 33 0.0006
882 COLITIS 24 0.0006
883 PRODUCT PREPARATION ERROR 13 0.0006
884 LUNG NEOPLASM MALIGNANT 26 0.0006
885 RESTLESSNESS 23 0.0006
886 ERECTILE DYSFUNCTION 16 0.0006
887 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
888 DEATH 535 0.0006
889 DISEASE PROGRESSION 73 0.0006
890 MENORRHAGIA 12 0.0006
891 ENCEPHALOPATHY 15 0.0006
892 URINARY RETENTION 20 0.0006
893 NEOPLASM MALIGNANT 40 0.0006
894 SPEECH DISORDER 31 0.0006
895 MELAENA 13 0.0006
896 INJECTION SITE PAIN 181 0.0006
897 MOOD ALTERED 16 0.0006
898 RESPIRATORY DISTRESS 16 0.0006
899 MENTAL IMPAIRMENT 14 0.0006
900 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 117 0.0006
901 HYPERGLYCAEMIA 21 0.0006
902 CHOLESTASIS 11 0.0006
903 DISEASE RECURRENCE 27 0.0006
904 DEVICE BREAKAGE 23 0.0006
905 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
906 JAUNDICE 15 0.0006
907 INJECTION SITE RASH 17 0.0006
908 MENTAL DISORDER 24 0.0006
909 HYPONATRAEMIA 31 0.0005
910 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
911 PRODUCT PRESCRIBING ERROR 13 0.0005
912 BLINDNESS 22 0.0005
913 NEUTROPHIL COUNT DECREASED 22 0.0005
914 DYSGEUSIA 40 0.0005
915 PRODUCT QUALITY ISSUE 73 0.0005
916 AGITATION 39 0.0005
917 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
918 ANGIOEDEMA 23 0.0005
919 EMOTIONAL DISORDER 16 0.0005
920 BLOOD BILIRUBIN INCREASED 14 0.0005
921 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
922 INJECTION SITE ERYTHEMA 64 0.0005
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
924 PALLOR 14 0.0005
925 INJECTION SITE MASS 19 0.0005
926 HYPERKALAEMIA 18 0.0005
927 METABOLIC ACIDOSIS 16 0.0005
928 CRYING 18 0.0005
929 MYOCARDIAL INFARCTION 86 0.0005
930 NEOPLASM PROGRESSION 17 0.0005
931 ARRHYTHMIA 23 0.0005
932 PNEUMONIA ASPIRATION 12 0.0005
933 NO ADVERSE EVENT 87 0.0005
934 ACUTE MYOCARDIAL INFARCTION 14 0.0005
935 HAEMATEMESIS 12 0.0005
936 CARDIOVASCULAR DISORDER 12 0.0005
937 RESPIRATORY ARREST 13 0.0005
938 INTENTIONAL OVERDOSE 30 0.0005
939 DEVICE USE ERROR 16 0.0005
940 CEREBROVASCULAR ACCIDENT 78 0.0005
941 BLOOD GLUCOSE DECREASED 22 0.0005
942 DEVICE ISSUE 41 0.0005
943 ANGINA PECTORIS 13 0.0005
944 PRODUCT SUBSTITUTION ISSUE 26 0.0005
945 PANCYTOPENIA 25 0.0004
946 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
947 MULTIPLE SCLEROSIS 21 0.0004
948 CARDIAC ARREST 36 0.0004
949 APHASIA 13 0.0004
950 CARDIO-RESPIRATORY ARREST 18 0.0004
951 MALIGNANT NEOPLASM PROGRESSION 44 0.0004
952 TARDIVE DYSKINESIA 12 0.0004
953 BLOOD GLUCOSE INCREASED 80 0.0004
954 MUCOSAL INFLAMMATION 11 0.0004
955 DRUG EFFECT INCOMPLETE 15 0.0004
956 OVERDOSE 89 0.0004
957 ABNORMAL BEHAVIOUR 16 0.0004
958 INCORRECT DOSE ADMINISTERED 92 0.0004
959 HEPATIC FAILURE 12 0.0004
960 DEMENTIA 11 0.0004
961 VAGINAL HAEMORRHAGE 17 0.0004
962 CARDIAC FAILURE 31 0.0004
963 CEREBRAL HAEMORRHAGE 13 0.0004
964 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
965 VISUAL ACUITY REDUCED 12 0.0004
966 DRUG DOSE OMISSION 59 0.0004
967 NERVOUS SYSTEM DISORDER 11 0.0004
968 HEPATIC FUNCTION ABNORMAL 13 0.0003
969 WITHDRAWAL SYNDROME 14 0.0003
970 RENAL FAILURE ACUTE 14 0.0003
971 DRUG DEPENDENCE 53 0.0003
972 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
973 EXTRA DOSE ADMINISTERED 13 0.0003
974 BRADYCARDIA 17 0.0003
975 TOXICITY TO VARIOUS AGENTS 54 0.0003
976 COMPLETED SUICIDE 26 0.0003
977 DRUG ABUSE 25 0.0003
978 DRUG WITHDRAWAL SYNDROME 26 0.0003
979 PRODUCT STORAGE ERROR 25 0.0003
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
981 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
982 DEVICE LEAKAGE 12 0.0003
983 COMA 13 0.0003
984 DEVICE MALFUNCTION 19 0.0003
985 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
986 INJECTION SITE HAEMORRHAGE 19 0.0002
987 CONVULSION 13 0.0002
988 AGGRESSION 11 0.0002
989 DEVICE DIFFICULT TO USE 13 0.0002
990 BREAST CANCER 16 0.0002